complexes that can match the reactivity of the SmI
combination.
2
/HMPA
using the HEPA complex. The rapidity and yield of the SmI
2
/
1
3,14
TPPA reduction is functionally equivalent to the results
2
,23
obtained by Inanaga with SmI
The reactivities of the SmI
2
/HMPA.
complexes with HMPA,
It is interesting to note that the ethyl analogue of HMPA,
hexaethylphosphoric acid triamide (HEPA, Figure 1), is not
2
HEPA, and TPPA were determined by measuring the rate
constant during the reduction of 1-bromodecane. In each
case, 1-bromodecane was added to a stirred 0.010 M solution
of SmI
2
containing the indicated amounts of each ligand,
-butanol and tetradecane. Sufficient quantities of SmI and
-butanol were included to ensure pseudofirst-order condi-
1
1
2
tions. Aliquots were removed and immediately quenched
with I . Gas chromatographic analyses of the resultant
2
2
4
mixtures were performed. Linear plots of reaction time vs
ln[1-bromodecane] were obtained in the HMPA and TPPA
cases allowing for the calculation of rate constants. The
HEPA kinetic analysis revealed no diminution of the
1-bromodecane nor measurable formation of decane, so a
Figure 1
.
2
Phosphoramides investigated in SmI reductions.
7
antispermatogenic. HEPA is 300 times less mutagenic than
1
5
HMPA in Drosophila melanogaster. Although it has not
been studied in detail, there is no evidence for toxicity or
mutagenicity for the tricyclic analogue of HEPA, tripyrro-
lidinophosphoric acid triamide (TPPA). We therefore inves-
tigated the synthetic utility of complexes formed between
SmI and the two phosphoramides HEPA and TPPA.
2
TPPA is particularly intriguing as a ligand because it is
known to be an excellent Lewis base. This ligand has a
2
rate constant could not be determined (Table 1). The SmI /
Table 1. Pseuofirst-Order Kinetic Study on the Effect of Ligand
on the Reduction of 1-Bromodecane at 21 °C
1
6,17
entry
ligand
k
obs (s-1)a
-
4
-4
-3
1
2
3
HMPA
TPPA
HEPA
7.0 × 10 ( 0.3 × 10
-3
2.0 × 10 ( 0.3 × 10
substantially higher exothermic heat of reaction with BF
than all of the other phosphoramides examined, including
3
-
a
1
8
[1-bromodecane] ) 0.0015 M, [SmI
M, [1-butanol] ) 0.020 M.
2
] ) 0.010 M, [ligand] ) 0.040
HMPA. TPPA also has a higher dipole moment than all
1
9
of the phosphoramides examined, including HMPA.
Both HEPA and TPPA are readily accessible. The
synthesis of TPPA can be accomplished in high yield by
TPPA complex is approximately three times more reactive
than the corresponding SmI /HMPA complex. This is
2
0
treating POCl
3
with excess pyrrolidine in ether. HEPA is
2
prepared by the oxidation of tris(diethylamino)phosphine
noteworthy because there is no previously reported evidence
2
1
with H
Initial experiments to probe the reactivity of the SmI
HEPA and SmI /TPPA complexes were executed as follows.
Purple soluble complexes were formed from SmI and 4
equiv of each ligand. Ten minutes after the addition of
2 2
O .
of an organic ligand which activates SmI toward the
2
reduction of alkyl halides to a greater extent than HMPA.
2
/
2
The low reactivity of the SmI /HEPA complex indicates that
2
HEPA does not activate SmI
value.
2
sufficiently to be of synthetic
2
To assist in the characterization of the reactivity of the
1
-bromodecane and tetradecane (internal standard), an aliquot
2
2
SmI /phosphoramide complexes, cyclic voltammetry was
2
was removed and quenched with I
2
.
Gas chromatographic
/TPPA
95%) were obtained. At 30 min of reaction time, the same
process indicated a chromatographic yield of 98% decane
utilized. Previously, addition of up to 3 equiv of HMPA to
2 2
yields of decane for SmI /HEPA (41%) and for SmI
4,25
2
SmI caused a negative shift in standard potential. A much
(
larger decrease was observed for 4 equiv of HMPA (0.72
V), which greatly increases its ability to perform reductions.
Because large excesses of HMPA (10 equiv) did not result
in further decreases in standard potential, it was concluded
(
(
(
13) Dahl e´ n, A.; Hilmersson, G. Eur. J. Inorg. Chem. 2004, 3393–3403
14) Kagan, H.; Namy, J. Top. Organomet. Chem. 1999, 2, 155–197
15) Zijlstra, J.; Brussee, J.; van der Gen, A.; Vogel, E. Mutat. Res.
.
.
that the species present under these conditions, [Sm(H-
1
989, 212, 193–211.
2+ 3,4
6
MPA) ] , exhibits reactivity toward organic functional
(
16) A recent report on the use of TPPA to improve a SmI -mediated
2
2
+
5
4 2
groups similar to [Sm(HMPA) (THF) ] . Recently, we
reductive cyanation has appeared: Ankner, T.; Friden-Saxin, M.; Pemberton,
N.; Seifert, T.; Grøtli, M.; Luthman, K.; Hilmersson, G. Org. Lett. 2010,
observed that 2 equiv of diHMPA produced a decrease in
1
2, 2210–2213
(
.
12
standard potential of 0.68 V.
17) Molander has previously reported the use of the related phosphora-
mide, tripiperidinophosphoric acid triamide: Molander, G. A.; McKie, J. A.
J. Org. Chem. 1993, 58, 7216–7227
Table 2 shows the standard potential of a series of SmI
2
/
.
HEPA complexes with varying equivalents of cosolvent. As
(
(
18) Maria, P.; Gal., J. J. Phys. Chem. 1985, 89, 1296–1304.
19) Ozari, Y.; Jagur-Grodzinski, J. J. Chem. Soc., Chem. Commun.
1
974, 295–296.
(23) In the absence of phosphoramide ligands, SmI
decane to decane in 4% yield after 10 min.
2
reduces 1-bromo-
(
20) Wilson, S.; Misra, R.; Georgiadis, G. J. Org. Chem. 1980, 45, 2460–
2
468.
(24) Fuh, M.; Lin, T.; Chang, S. Talanta 1998, 46, 861–866.
(
(
21) Stuebe, C.; Lankelma, H. J. Am. Chem. Soc. 1956, 78, 976–977.
22) Dahl e´ n, A.; Hilmersson, G. Chem.sEur. J. 2003, 9, 1123–1128.
(25) Shabangi, M.; Flowers, R. A.II. Tetrahedron Lett. 1997, 38, 1137–
1140
.
Org. Lett., Vol. 12, No. 22, 2010
5179